ADVA Biotechnologies
A well-known international expert in cell therapy. Dr. Karnieli is the founder and former CEO of Atvio Biotech, a leading Innovation center for cell & gene therapy that was sold to Orgenesis Inc. in 2018. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP of the medical device at Goji Solutions. Dr. Karnieli served as the chair of the process & product development committee of the International Society for Cellular Therapies, as an expert member of the ISO TC276 Biotechnology standard committee, and was the former chair of the Science and technology committee of the Alliance for Regenerative Medicine.
This person is not in any offices
ADVA Biotechnologies
ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution.ADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability,reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.